SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013951
Filing Date
2023-05-11
Accepted
2023-05-11 16:20:49
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eton20230331_10q.htm   iXBRL 10-Q 697277
2 EXHIBIT 31.1 ex_481024.htm EX-31.1 8792
3 EXHIBIT 31.2 ex_481025.htm EX-31.2 8795
4 EXHIBIT 32.1 ex_481026.htm EX-32.1 6495
  Complete submission text file 0001437749-23-013951.txt   4843596

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eton-20230331.xsd EX-101.SCH 50802
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eton-20230331_cal.xml EX-101.CAL 33354
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20230331_def.xml EX-101.DEF 380755
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20230331_lab.xml EX-101.LAB 350458
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20230331_pre.xml EX-101.PRE 403728
52 EXTRACTED XBRL INSTANCE DOCUMENT eton20230331_10q_htm.xml XML 568760
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 23911371
SIC: 2834 Pharmaceutical Preparations